XML 20 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash Flows From Operating Activities:      
Net Income $ 50,538,000 $ 53,143,000 $ 53,369,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 39,023,000 37,114,000 34,384,000
Provision for Doubtful Accounts 5,967,000 6,583,000 6,228,000
Equity in earnings of unconsolidated investments (6,636,000) (5,845,000) (6,675,000)
Distributions from unconsolidated investments 8,059,000 6,505,000 10,288,000
Gains on sale of marketable securities (816,000) (566,000) (379,000)
Deferred income taxes 4,791,000 (648,000) (1,434,000)
Stock–based compensation 509,000 1,982,000 2,021,000
Changes in operating assets and liabilities, net of the effect of acquisitions:      
Accounts receivable (4,403,000) (11,835,000) (5,215,000)
Income tax receivable (1,462,000) 1,524,000 (4,727,000)
Inventories 60,000 (441,000) 19,000
Prepaid expenses and other assets (477,000) 89,000 (2,587,000)
Trade accounts payable (1,535,000) 4,251,000 2,827,000
Accrued payroll 574,000 5,479,000 (3,603,000)
Amounts due to third party payors 365,000 (6,277,000) 1,312,000
Other current liabilities and accrued risk reserves (3,526,000) (7,455,000) (5,652,000)
Obligation to provide future services (204,000) (487,000) 238,000
Other noncurrent liabilities 8,000 283,000 1,486,000
Deferred revenue 47,000 (44,000) 39,000
Net cash provided by operating activities 90,882,000 83,355,000 81,939,000
Cash Flows From Investing Activities:      
Additions to property and equipment (62,601,000) (58,416,000) (53,298,000)
Investments in unconsolidated companies (1,282,000) (674,000) (1,975,000)
Acquisition of non–controlling interest (768,000)
Investments in notes receivable (5,251,000) (5,676,000) (767,000)
Collections of notes receivable 1,636,000 4,948,000 3,156,000
Purchases of marketable securities (48,620,000) (60,540,000) (62,165,000)
Sale of marketable securities 34,642,000 47,574,000 48,786,000
Net cash used in investing activities (81,476,000) (72,784,000) (67,031,000)
Cash Flows From Financing Activities:      
Borrowings under credit facility 110,000,000
Redemption of preferred shareholders (130,538,000)
Principal payments under capital lease obligations (3,278,000) (3,089,000) (2,436,000)
Dividends paid to preferred stockholders (8,986,000) (8,670,000)
Dividends paid to common stockholders (25,795,000) (21,089,000) (18,704,000)
Issuance of common shares 10,772,000 10,634,000 7,429,000
Repurchase of common shares (8,195,000) (6,995,000)
Tax (expense) benefit from exercise of stock options (1,096,000) 1,942,000 201,000
Debt issuance costs (601,000)
Entrance fee deposits (refunds) 59,000 (354,000) (501,000)
Change in deposits 402,000 406,000 (448,000)
Net cash used in financing activities (27,131,000) (41,675,000) (30,124,000)
Net Decrease in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents (17,725,000) (31,104,000) (15,216,000)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning of Period 49,314,000 80,418,000 95,634,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, End of Period 31,589,000 49,314,000 80,418,000
Balance Sheet Classifications:      
Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 49,314,000 49,314,000 80,418,000
Supplemental Information:      
Cash payments for interest 4,528,000 2,965,000 2,242,000
Cash payments for income taxes 27,668,000 29,183,000 36,642,000
Non–cash financing and investing activities include:      
Buildings, personal property, and obligations recorded under capital lease agreements $ 39,032,000